About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Baltimore | 13,687 Studies Near You

Clinical TrialsBaltimore

Clinical Trials in Baltimore

Discover 13,687 clinical trials near Baltimore, Maryland. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 1341-1360 of 13,687 trials

CompletedCarboplatin and Paclitaxel With or Without Sorafenib Tosylate in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by SurgeryThis randomized phase III trial studies carboplatin, paclitaxel, and sorafenib tosylate to see how well they work compared to carboplatin and paclitaxel in treating patients with…NCT00110019·Birmingham, Alabama and 218 others

Find Trials by Condition in Baltimore

Breast Cancerin Baltimore Lung Cancerin Baltimore Prostate Cancerin Baltimore Colorectal Cancerin Baltimore Melanomain Baltimore Leukemiain Baltimore Lymphomain Baltimore Pancreatic Cancerin Baltimore Ovarian Cancerin Baltimore Brain Cancerin Baltimore

Data from ClinicalTrials.govTerms

Active not recruitingCasting vs Bracing for Idiopathic Early-Onset ScoliosisComparison of casting and bracing for the treatment of idiopathic early onset scoliosisNCT04500041·Little Rock, Arkansas and 25 others

CompletedTailored Home-Based Exercise Program for Multiple Chronic ConditionsA home-based, tailored, technology-enhanced home-based exercise program (iHBE) using a combination of the integrated mobile technologies (wearable device and phone application)…NCT03874754·Baltimore, Maryland

Active not recruitingCentral Vein Sign: a Diagnostic Biomarker in Multiple SclerosisThe need for improved diagnostic methods in Multiple Sclerosis (MS) is widely recognized.NCT04495556·Los Angeles, California and 10 others

TerminatedA Study to Evaluate Pharmacokinetics, Pharmacodynamics and Tissue Concentrations of EpelsibanThis multi-cohort phase I study is designed to assess the pharmacokinetics (PK) and pharmacodynamics (PD) of oxytocin and to evaluate epelsiban (GSK557296) potential to reduce…NCT02213029·Glendale, California and 1 other

CompletedSafety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Symptomatic Severe Aortic Stenosis in High Risk and Very High Risk Subjects Who Need Aortic Valve ReplacementThe purpose of the study is to evaluate the safety and efficacy of the Medtronic CoreValve® System in the treatment of symptomatic severe aortic stenosis in subjects who have a…NCT01240902·Phoenix, Arizona and 44 others

TerminatedMulticenter,Single-arm Study to Evaluate Efficacy, Safety, & Pharmacokinetics of Denosumab in Children w/ OIThis is a prospective, multicenter, single-arm study in children 2 to 17 years of age with OI to evaluate efficacy and safety of denosumab.NCT02352753·Los Angeles, California and 48 others

TerminatedFirst-Line Treatment for Locally Advanced or Metastatic Mesenchymal Epithelial Transition Factor (MET) - Positive Gastric, Lower Esophageal, or Gastroesophageal Junction (GEJ) AdenocarcinomaThis is a phase 3, multicenter, randomized, double-blind, placebo controlled study of epirubicin, cisplatin \& capecitabine (ECX) with rilotumumab or placebo for untreated…NCT01697072·Tucson, Arizona and 188 others

CompletedH7N9 Mix and Match With MF59 in Healthy Elderly PersonsThis is a Phase II randomized, partially-blinded, controlled trial in 360 (up to 600) males and females, 65 years of age and older, who are in good health and meet all eligibility…NCT02213354·Decatur, Georgia and 9 others

TerminatedPassport to Freedom (P2F): Adaptation and Implementation of a Wellness ProgramWomen currently residing at an emergency shelter for women and children will participate in group sessions that cover topics that promote physical and emotional well-being through…NCT04069754·Baltimore, Maryland

TerminatedFixation Using Alternative Implants for the Treatment of Hip Fractures (FAITH-2)The purpose of this study is to determine the impact of surgical fixation (cancellous screws versus sliding hip screws) and biologic intervention (Vitamin D versus placebo) on…NCT01908751·Phoenix, Arizona and 19 others

CompletedBAY63-2521 - Long-term Extension Study in Patients With Chronic Thromboembolic Pulmonary HypertensionPatients who have completed the 16 weeks treatment of the CHEST-1 trial (study number 11348) will be asked to participate in this long term extension study with BAY63-2521.NCT00910429·La Jolla, California and 72 others

CompletedA 6-week, Study of MG01CI Low Dose and High Dose Compared With Placebo in Adults and Adolescents With Fragile X SyndromeThis study is a multisite, randomized, double-blind, placebo-controlled, phase 2 study of MG01CI (low dose and high dose once daily) for 6 weeks compared with placebo in a 1:1…NCT02126995·Phoenix, Arizona and 11 others

CompletedA Study for Patients With Neurogenic Orthostatic HypotensionWe are seeking male and female patients to voluntarily take part in a clinical research study.NCT00046475·Huntsville, Alabama and 14 others

Active not recruitingResponse and Biology-Based Risk Factor-Guided Therapy in Treating Younger Patients With Non-high Risk NeuroblastomaThis phase III trial studies how well response and biology-based risk factor-guided therapy works in treating younger patients with non-high risk neuroblastoma.NCT02176967·Birmingham, Alabama and 221 others

CompletedEfficacy and Safety of Alisporivir Triple Therapy in Chronic Hepatitis C Genotype 1 Treatment-naïve ParticipantsThis study will assess the safety and efficacy of alisporivir (ALV; DEB025) triple therapy \[i.e., when added to peginterferon alfa-2a (PEG) and ribavirin (RBV)\] to optimize…NCT01318694·Beverly Hills, California and 145 others

CompletedLorvotuzumab Mertansine in Treating Younger Patients With Relapsed or Refractory Wilms Tumor, Rhabdomyosarcoma, Neuroblastoma, Pleuropulmonary Blastoma, Malignant Peripheral Nerve Sheath Tumor, or Synovial SarcomaThis phase II trial studies how well lorvotuzumab mertansine works in treating younger patients with Wilms tumor, rhabdomyosarcoma, neuroblastoma, pleuropulmonary blastoma…NCT02452554·Birmingham, Alabama and 68 others

TerminatedSafety and Tolerability of the Ketogenic Diet in Amyotrophic Lateral Sclerosis (ALS)This research is being done to see if the ketogenic diet (which is high in fat and low in carbohydrates) is safe and tolerable in amyotrophic lateral sclerosis (ALS) patients who…NCT01016522·Baltimore, Maryland

CompletedEfficacy and Safety of Adalimumab in Patients With Active Rheumatoid Arthritis Treated Concomitantly With Methotrexate.The purpose of the study was to assess the safety, immunogenicity, and clinical efficacy of adalimumab compared with placebo (during double-blind phase) and to to evaluate the…NCT00195702·Huntsville, Alabama and 86 others

RecruitingBaltimore Longitudinal Study of AgingBackground: \- The Baltimore Longitudinal Study of Aging (BLSA) is a clinical research program on human aging that began in 1958.NCT00233272·Baltimore, Maryland

PreviousPage 68 of 685Next

Diabetes

in Baltimore

Heart Diseasein Baltimore